1. In Vivo
  2. >>Global Vision

Greater Bay Area Device Adoption Can Be A Steppingstone To China Uptake

Innovative Products Stand To Benefit Most

 
• By Ashley Yeo

Medical devices selected for use in the Guangdong-Hong Kong-Macao Greater Bay Area may potentially be fast-tracked for adoption across mainland China, according to a new industry white paper.

Shutterstock
• Source: Shutterstock

A multi-sector initiative signed in 2017 in the presence of Chinese president Xi Jinping to set up the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) is now increasingly being leveraged by medical device and drug companies with products listed for use in public hospitals in Hong Kong and Macao.

In 2021, the Guangdong Provincial Medical Products Administration (MPA) and the health commission of Guangdong Province introduced interim regulations setting up a system to cover urgent clinical needs in China. The GBA has a population of some 86 million

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Global Vision

More from In Vivo

NewAmsterdam’s Davidson On Reviving “Failed” Drug Class To Fill Cardiovascular Treatment Gap

 
• By David Wild

After a string of high-profile failures by big pharma, Michael Davidson is positioning his company's CETP inhibitor as the next breakthrough in cardiovascular medicine. The body of data to support this position is growing.

Dealmaking Quarterly Statistics, Q1 2025

 
• By Deanna Kamienski and Maureen Riordan

During Q1, biopharma M&A deal value reached $38.4bn and drew in $60.8bn in potential deal value from alliances. Device company M&A values reached $8.7bn.

Rising Leaders 2025: Flagship’s Jacob Rubens On Building The Next Generation Of Biotech

 
• By David Wild

Rising Leader Jacob Rubens, who has co-founded and led several Flagship companies and is now origination partner, believes aspiring leaders should follow their bliss.